Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
17.7
32
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Yantai Zhenghai Bio-Tech Co Ltd
Total Current Assets
Yantai Zhenghai Bio-Tech Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
|
Total Current Assets
ÂĄ686.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
||
Beigene Ltd
HKEX:6160
|
Total Current Assets
ÂĄ29.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
||
Akeso Inc
HKEX:9926
|
Total Current Assets
ÂĄ3.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Current Assets
ÂĄ10.3B
|
CAGR 3-Years
73%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
||
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Total Current Assets
ÂĄ8.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
||
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Current Assets
ÂĄ46.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
41%
|
CAGR 10-Years
40%
|
Yantai Zhenghai Bio-Tech Co Ltd
Glance View
Yantai Zhenghai Bio-Tech Co., Ltd. engages in the research & development, production, and sale of regenerative medicine related products such as soft tissue, and hard tissue repair materials. The company is headquartered in Yantai, Shandong and currently employs 378 full-time employees. The company went IPO on 2017-05-16. The firm has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.
See Also
What is Yantai Zhenghai Bio-Tech Co Ltd's Total Current Assets?
Total Current Assets
686.1m
CNY
Based on the financial report for Sep 30, 2024, Yantai Zhenghai Bio-Tech Co Ltd's Total Current Assets amounts to 686.1m CNY.
What is Yantai Zhenghai Bio-Tech Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
6%
Over the last year, the Total Current Assets growth was -5%. The average annual Total Current Assets growth rates for Yantai Zhenghai Bio-Tech Co Ltd have been 4% over the past three years , 6% over the past five years .